These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9675226)

  • 1. Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterization.
    Catimel B; Scott AM; Lee FT; Hanai N; Ritter G; Welt S; Old LJ; Burgess AW; Nice EC
    Glycobiology; 1998 Sep; 8(9):927-38. PubMed ID: 9675226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant antibodies against ganglioside expressed on tumor cells.
    Hanai N; Nakamura K; Shitara K
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2.
    Karlsson G; Månsson JE; Wikstrand C; Bigner D; Svennerholm L
    Biochim Biophys Acta; 1990 Apr; 1043(3):267-72. PubMed ID: 1691018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.
    Ohta S; Honda A; Tokutake Y; Yoshida H; Hanai N
    Cancer Immunol Immunother; 1993; 36(4):260-6. PubMed ID: 8439988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo.
    Fukumoto H; Nishio K; Ohta S; Hanai N; Fukuoka K; Ohe Y; Sugihara K; Kodama T; Saijo N
    Int J Cancer; 1999 Aug; 82(5):759-64. PubMed ID: 10417777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance.
    Kuziemko GM; Stroh M; Stevens RC
    Biochemistry; 1996 May; 35(20):6375-84. PubMed ID: 8639583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membranes.
    Chabraoui F; Derrington EA; Mallie-Didier F; Confavreux C; Quincy C; Caudie C
    J Immunol Methods; 1993 Oct; 165(2):225-30. PubMed ID: 8228272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cholera toxin-ganglioside interactions by flow cytometry.
    Lauer S; Goldstein B; Nolan RL; Nolan JP
    Biochemistry; 2002 Feb; 41(6):1742-51. PubMed ID: 11827518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ganglioside-based assay for cholera toxin using an array biosensor.
    Rowe-Taitt CA; Cras JJ; Patterson CH; Golden JP; Ligler FS
    Anal Biochem; 2000 May; 281(1):123-33. PubMed ID: 10847619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity.
    Critchley DR; Streuli CH; Kellie S; Ansell S; Patel B
    Biochem J; 1982 Apr; 204(1):209-19. PubMed ID: 7052064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside.
    Chapman PB; Yuasa H; Houghton AN
    J Immunol; 1990 Aug; 145(3):891-8. PubMed ID: 1695649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
    Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
    Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array.
    Worstell NC; Krishnan P; Weatherston JD; Wu HJ
    PLoS One; 2016; 11(4):e0153265. PubMed ID: 27070150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.
    Alfonso M; Vázquez AM; Carr A; Haerslev T; Fernández LE; Lanio ME; Alvarez C; Zeuthen J; Pérez R
    Hybridoma; 1995 Jun; 14(3):209-16. PubMed ID: 7590782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions.
    Nakamura K; Tanaka Y; Shitara K; Hanai N
    Cancer Immunol Immunother; 2001 Jul; 50(5):275-84. PubMed ID: 11499811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of gangliosides from carp intestinal mucosa.
    Irie T; Watarai S; Kushi Y; Kasama T; Kodama H
    Fish Shellfish Immunol; 2004 Feb; 16(2):117-25. PubMed ID: 15123316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative measurements of the interaction between monosialoganglioside monolayers and wheat germ agglutinin (WGA) by a quartz-crystal microbalance.
    Sato T; Serizawa T; Ohtake F; Nakamura M; Terabayashi T; Kawanishi Y; Okahata Y
    Biochim Biophys Acta; 1998 Mar; 1380(1):82-92. PubMed ID: 9545544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.